CNS Pharmaceuticals(CNSP) - 2025 Q3 - Quarterly Report

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 (Name of registrant as specified in its charter) (State or other jurisdiction of Incorporation or Organization) (I.R.S. Employer identification No.) 2100 West Loop South, Suite 900 Houston, Texas 77027 (Address of principal executive offices (Zip Code) Nevada 82-2318545 OR ☐ TRANSITION R ...